Albuminuria lowering effect of dapagliflozin, exenatide and their combination in patients with type 2 diabetes: a randomised cross-over clinical trial

被引：0
|
作者：
van der Aart-van der Beek, A. B. [1 ,2 ]
Apperloo, E. [3 ]
Jongs, N. [1 ]
Rouw, D. B. [2 ]
Sjostrom, D. [4 ]
van Raalte, D. H. [5 ]
Hoogenberg, K. [2 ]
Heerspink, H. J. L. [1 ]
机构：
[1] Univ Groningen, Groningen, Netherlands
[2] Martini Hosp, Groningen, Netherlands
[3] Isala Hosp, Groningen, Netherlands
[4] AstraZeneca, Gothenburg, Sweden
[5] Amsterdam UMC, Amsterdam, Netherlands
来源：
DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
750
引用
收藏
页码：S387 / S387
页数：1
相关论文
共 50 条
  • [31] The effect of uric acid lowering treatment on albuminuria and renal function in Type 1 diabetes: a randomized clinical trial
    Pilemann-Lyberg, S.
    Persson, F.
    Frystyk, J.
    Rossing, P.
    DIABETIC MEDICINE, 2018, 35 (03) : 392 - 393
  • [32] The VEPRO trial: A cross-over randomised controlled trial comparing 2 progressive lenses for patients with presbyopia
    Isabelle Boutron
    Caroline Touizer
    Isabelle Pitrou
    Carine Roy
    Philippe Ravaud
    Trials, 9
  • [33] The VEPRO trial: A cross-over randomised controlled trial comparing 2 progressive lenses for patients with presbyopia
    Boutron, Isabelle
    Touizer, Caroline
    Pitrou, Isabelle
    Roy, Carine
    Ravaud, Philippe
    TRIALS, 2008, 9 (1)
  • [34] The effect of purslane seeds on glycemic status and lipid profiles of persons with type 2 diabetes: A randomized controlled cross-over clinical trial
    Esmaillzadeh, Ahmad
    Zakizadeh, Elahe
    Faghihimani, Elham
    Gohari, Mahmoodreza
    Jazayeri, Shima
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2015, 20 (01): : 47 - 53
  • [35] Improvement in myocardial energetics and perfusion with Liraglutide in patients with type 2 diabetes- A randomised, single centre, open label, cross-over drug trial
    Chowdhary, A.
    Thirunavukarasu, S.
    Jex, N.
    Kotha, S.
    Giannoudi, M.
    Proctor, H.
    Kellman, P.
    Greenwood, J. P.
    Plein, S.
    Levelt, E.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [36] Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)-study protocol
    Rajeev, Surya Panicker
    Sprung, Victoria S.
    Roberts, Carl
    Harrold, Jo A.
    Halford, Jason C. G.
    Stancak, Andrej
    Boyland, Emma J.
    Kemp, Graham J.
    Cuthbertson, Daniel J.
    Wilding, John P. H.
    BMJ OPEN, 2017, 7 (01):
  • [37] A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol
    Brown, Emily
    Wilton, Moon M.
    Sprung, Victoria S.
    Harrold, Joanne A.
    Halford, Jason C. G.
    Stancak, Andrej
    Burgess, Malcolm
    Howarth, Elaine
    Umpleby, A. Margot
    Kemp, Graham J.
    Wilding, John P. H.
    Cuthbertson, Daniel J.
    BMJ OPEN, 2021, 11 (07):
  • [38] Effect of opaque wraps for pulse oximeter sensors: randomised cross-over trial
    Loganathan, Prakash Kannan
    O'Shea, Joyce E.
    Harikumar, Chidambara
    Brigham, John C.
    Rabi, Yacov
    Gupta, Samir
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2021, 106 (01): : F57 - F61
  • [39] Divided consumption of late-night-dinner improves glycemic excursions in patients with type 2 diabetes: A randomized cross-over clinical trial
    Imai, Saeko
    Kajiyama, Shizuo
    Hashimoto, Yoshitaka
    Yamane, Chikako
    Miyawaki, Takashi
    Ozasa, Neiko
    Tanaka, Muhei
    Fukui, Michiaki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 129 : 206 - 212
  • [40] Positive impact of liraglutide on pulmonary function in patients with type 2 diabetes: data from the randomised cross-over LIRALUNG study
    Lopez-Cano, C.
    Ciudin, A.
    Sanchez, E.
    Tinahones, F.
    Soto, A.
    Pellitero, S.
    Barbe, F.
    Dalmases, M.
    Garcia-Ramirez, M.
    Gaeta, A.
    Marti, R.
    Hernandez, C.
    Simo, R.
    Lecube, A.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 99 - 100
12345